<p>Bevacizumab use in the treatment of cancer can lead to the development of hypertension in some patients, and high-grade toxicity can limit therapy or lead to cardiovascular complications. The factors that contribute to interindividual variability in blood pressure rise during bevacizumab treatment are not well understood. In the present study, whole exomes and flanking regulatory regions of candidate genes associated with vasodilation and blood pressure were sequenced in bevacizumab-treated subjects with the objective of identifying genes harboring multiple variants associated with severe, early-onset bevacizumab-induced hypertension.</p>

Genomic Analysis of Bevacizumab-induced Hypertension

Hypertension study with SNP Genotypes (NGS) data on dbGaP (62 participants)

Genomic Analysis of Bevacizumab-induced Hypertension

Description

Applying For Access

Summary